J L Montastruc - Concepedia

Author

J L Montastruc

Also Known As

J L Montastruc, J. L. Montastruc, J.-L. Montastruc, J.L Montastruc, J.L. MONTASTRUC, J.L. Montastruc, JL Montastruc, Jean-Louis Montastruc, Montastruc, J.L., P. Jaillon

Publications

975

Citations

H-Index

Concepts

All Affiliations

Inserm Pharmacochimie et Pharmacologie pour le Développement Centre Hospitalier Universitaire de Toulouse Hôpital Purpan Observatoire Midi-Pyrénées

About

J L Montastruc is an author at Inserm specializing in medicine, neurology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	451
2	Health Sciences	3	3	252
3	Social Sciences	1	1	79
4	Anesthesia	1	1	79
5	Biochemistry	1	1	84

J L Montastruc

Publications

720

Citations

H-Index

Page 1

	Year	Citations
Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats F. Cesselin, J L Montastruc, Christelle Gross, Brain Research Health SciencesPain MedicineNeuroanatomyChronic Suffering RatsMedicine	1980	131
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. Philippe Valet, M Berlan, M Beauville, Journal of Clinical Investigation ImmunologyGastrointestinal Peptide HormoneMetabolic SyndromePeptide YyRegulatory Peptides	1990	84
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Núria Andreu, Jean-Jacques Chalé, Jean‐Michel Sénard, PubMed NeuropsychologyDopaminergic Drugs ComplainPharmacotherapyAnesthetic AdministrationSocial Sciences	1999	79
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension Jean‐Michel Sénard, B Chamontin, A Rascol, Clinical Autonomic Research HypertensionBlood PressureAmbulatory Blood PressureAntihypertensive TherapyParkinson Disease	1992	73
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. M Berlan, J Galitzky, Alain Bousquet‐mélou, Journal of Pharmacology and Experimental Therapeutics	1994	66
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. Geneviève Tavernier, J Galitzky, Alain Bousquet‐mélou, Journal of Pharmacology and Experimental Therapeutics	1992	57
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study L. Sailler, Celice Cordeiro de Souza Bergh Pereira, Ashley Bagheri, Annals of the Rheumatic Diseases	2007	42
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]. M E Llau, L Nguyen, Jean‐Michel Sénard, PubMed	1994	39
Consensus statement on dementia of Alzheimer type in the severe stage. B. Vellas, Serge Gauthier, H. Allain, PubMed Neurodegenerative DiseasesAlzheimer TypeAlzheimer's DiseaseAgingPsychiatry	2006	37
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog. Philippe Valet, J L Montastruc, M Berlan, Journal of Pharmacology and Experimental Therapeutics	1989	22

Page 1